Ido Weiss

Ido Weiss has worked in the research field since 2008. Ido began their career as a Visiting Fellow at the National Institute of Allergy and Infectious Diseases (NIAID), where they developed PET imaging tracers targeting CXCR4 and other targets and evaluated these tracers in preclinical tumor models, as well as studied the role of chemokine receptors in the development of antigen specific memory T cells in mice. In 2011, they moved to Amnon Peled's lab as a Senior Staff Scientist, where they developed a novel single nodal lung cancer mouse model and assisted graduate students with orthotopic tumors in the adrenal, pancreas and prostate. Ido then moved to the National Institute of Allergy and Infectious Diseases (NIAID), Farber's lab in 2013 as a Research Fellow. In 2016, they joined Immunomic Therapeutics, Inc. as a Scientist. In 2018, they moved to WindMIL Therapeutics as a Scientist. In 2019, they joined NextCure, Inc. as an Associate Director of Translational Research, and in 2021 they joined OncoC4, Inc. as the Director of Translational Research.

Ido Weiss obtained a Ph.D. in Immunology from The Hebrew University of Jerusalem between 2002 and 2008. From 2008 to 2011, they completed a post doc in Immunology, T cells, and Positron emission tomography (PET) Imaging of cancer biomarker at NIH/NIAID. In addition, they have obtained several Coursera Course Certificates in Reproducible Research, Statistical Inference, Exploratory Data Analysis, Getting and Cleaning Data, R Programming, and The Data Scientist’s Toolbox between 2015 and 2016.